Literature DB >> 2481447

Effects of clenbuterol and propranolol on muscle mass. Evidence that clenbuterol stimulates muscle beta-adrenoceptors to induce hypertrophy.

P A MacLennan1, R H Edwards.   

Abstract

1. A single subcutaneous injection of clenbuterol hydrochloride (0.125 mg/kg body wt.) to female Wistar rats produced a rapid increase in muscle cyclic AMP and lactate concentrations and a decrease in muscle glycogen concentrations. These changes are characteristic of muscle beta-adrenoceptor stimulation and were abolished by intraperitoneal injection of propranolol (12.5 mg/kg) 15 min before clenbuterol administration. 2. When this dose of clenbuterol was injected twice daily, the changes in muscle metabolite concentrations which followed its acute administration persisted until day 7 of treatment, and were accompanied by increases in muscle mass, body weight and muscle protein synthesis rate (ks). When the clenbuterol injections were preceded by propranolol injections (12.5 mg/kg administered according to the protocol described above), or if animals were treated with propranolol only, the values of these variables were not significantly different from those of sham-injected controls. 3. In rats fed on a semi-synthetic diet (PW3) supplemented with 2 mg of clenbuterol/kg of diet for 7 days, the muscle mass was greater than that of rats fed on unsupplemented PW3. The increased muscle mass was accompanied by increased muscle lactate and decreased muscle glycogen concentrations. When PW3 was supplemented with 2 mg of clenbuterol/kg and 200 mg of propranolol/kg, the increase in muscle mass remained, but decreased muscle glycogen concentrations and increased muscle lactate concentrations were also observed. 4. These data are consistent with the hypothesis that clenbuterol influences muscle growth via beta-adrenoceptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2481447      PMCID: PMC1133617          DOI: 10.1042/bj2640573

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  Propranolol apparently separates the physical and compositional characteristics of muscle growth induced by clenbuterol.

Authors:  C A Maltin; M I Delday; S M Hay; F G Smith; P J Reeds
Journal:  Biosci Rep       Date:  1987-01       Impact factor: 3.840

2.  Clenbuterol, a beta agonist, induces growth in innervated and denervated rat soleus muscle via apparently different mechanisms.

Authors:  C A Maltin; S M Hay; M I Delday; F G Smith; G E Lobley; P J Reeds
Journal:  Biosci Rep       Date:  1987-06       Impact factor: 3.840

3.  Evidence that the hypertrophic action of clenbuterol on denervated rat muscle is not propranolol-sensitive.

Authors:  C A Maltin; S M Hay; M I Delday; P J Reeds; R M Palmer
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

4.  Effect of a selective beta 2-adrenergic agonist (clenbuterol) on energy balance and body composition in normal and protein deficient rats.

Authors:  N J Rothwell; M J Stock
Journal:  Biosci Rep       Date:  1987-12       Impact factor: 3.840

5.  Stimulation of muscle growth by clenbuterol: lack of effect on muscle protein biosynthesis.

Authors:  P J Reeds; S M Hay; P M Dorwood; R M Palmer
Journal:  Br J Nutr       Date:  1986-07       Impact factor: 3.718

6.  Slow to fast alterations in skeletal muscle fibers caused by clenbuterol, a beta 2-receptor agonist.

Authors:  R J Zeman; R Ludemann; T G Easton; J D Etlinger
Journal:  Am J Physiol       Date:  1988-06

7.  Cyclic nucleotides and contractility of isolated soleus muscle.

Authors:  W C Bowman; F Y Lam; I W Rodger; M Shahid
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

8.  The rate of substrate cycling between fructose 6-phosphate and fructose 1,6-bisphosphate in skeletal muscle.

Authors:  R A Challiss; J R Arch; E A Newsholme
Journal:  Biochem J       Date:  1984-07-01       Impact factor: 3.857

9.  Clenbuterol, a beta 2-agonist, retards atrophy in denervated muscles.

Authors:  R J Zeman; R Ludemann; J D Etlinger
Journal:  Am J Physiol       Date:  1987-01

10.  The effect of beta-agonists and antagonists on muscle growth and body composition of young rats (Rattus sp.).

Authors:  P J Reeds; S M Hay; P M Dorward; R M Palmer
Journal:  Comp Biochem Physiol C       Date:  1988
View more
  20 in total

1.  The effects of clenbuterol on satellite cell activation and the regeneration of skeletal muscle: an autoradiographic and morphometric study of whole muscle transplants in mice.

Authors:  P Roberts; J K McGeachie
Journal:  J Anat       Date:  1992-02       Impact factor: 2.610

2.  Evaluation of antihypertensive drugs in combination with enzyme replacement therapy in mice with Pompe disease.

Authors:  Sang-Oh Han; Alexina C Haynes; Songtao Li; Dennis M Abraham; Priya S Kishnani; Richard Steet; Dwight D Koeberl
Journal:  Mol Genet Metab       Date:  2019-10-17       Impact factor: 4.797

3.  Effects of clenbuterol, ICI118551 and sotalol on the growth of cardiac and skeletal muscle and on beta 2-adrenoceptor density in female rats.

Authors:  M N Sillence; M L Matthews; W G Spiers; G G Pegg; D B Lindsay
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

4.  Clenbuterol: a medal in tablet form?

Authors:  H Perry
Journal:  Br J Sports Med       Date:  1993-06       Impact factor: 13.800

5.  Clenbuterol has a greater influence on untrained than on previously trained skeletal muscle in rats.

Authors:  R J Murphy; L Béliveau; K L Seburn; P F Gardiner
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

6.  Adjunctive β2-agonists reverse neuromuscular involvement in murine Pompe disease.

Authors:  Songtao Li; Baodong Sun; Mats I Nilsson; Andrew Bird; Mark A Tarnopolsky; Beth L Thurberg; Deeksha Bali; Dwight D Koeberl
Journal:  FASEB J       Date:  2012-09-19       Impact factor: 5.191

7.  β2 Agonists enhance the efficacy of simultaneous enzyme replacement therapy in murine Pompe disease.

Authors:  Dwight D Koeberl; Songtao Li; Jian Dai; Beth L Thurberg; Deeksha Bali; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2011-11-11       Impact factor: 4.797

8.  Therapeutic clenbuterol treatment does not alter Ca2+ sensitivity of permeabilized fast muscle fibres from exercise trained or untrained horses.

Authors:  David R Plant; Charles F Kearns; Kenneth H McKeever; Gordon S Lynch
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

9.  Salbutamol exhibits androgenic activity in vitro.

Authors:  André O von Bueren; Risheng Ma; Margret Schlumpf; Walter Lichtensteiger
Journal:  Br J Sports Med       Date:  2007-05-17       Impact factor: 13.800

10.  Effects of clenbuterol, a β₂-adrenergic agonist, on sizes of masseter, temporalis, digastric, and tongue muscles.

Authors:  Chieko Ishikawa; Takumi Ogawa; Tomoko Ikawa; Akira Yamane
Journal:  Open Dent J       Date:  2009-09-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.